Managing COVID-19 within and across health systems:why we need performance intelligence to coordinate a global response by Kringos, D et al.
 
  
 
Aalborg Universitet
Managing COVID-19 within and across health systems
why we need performance intelligence to coordinate a global response
Kringos, D; Carinci, F; Barbazza, E; Bos, V; Gilmore, K; Groene, O; Gulácsi, L; Ivankovic, D;
Jansen, T; Johnsen, S P; de Lusignan, S; Mainz, J; Nuti, S; Klazinga, N; HealthPros Network
Published in:
Health Research Policy and Systems
DOI (link to publication from Publisher):
10.1186/s12961-020-00593-x
Creative Commons License
CC BY 4.0
Publication date:
2020
Document Version
Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Kringos, D., Carinci, F., Barbazza, E., Bos, V., Gilmore, K., Groene, O., Gulácsi, L., Ivankovic, D., Jansen, T.,
Johnsen, S. P., de Lusignan, S., Mainz, J., Nuti, S., Klazinga, N., & HealthPros Network (2020). Managing
COVID-19 within and across health systems: why we need performance intelligence to coordinate a global
response. Health Research Policy and Systems, 18(1), [80]. https://doi.org/10.1186/s12961-020-00593-x
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.
Downloaded from vbn.aau.dk on: December 26, 2020
COMMENTARY Open Access
Managing COVID-19 within and across
health systems: why we need performance
intelligence to coordinate a global
response
D. Kringos1* , F. Carinci2, E. Barbazza1, V. Bos1, K. Gilmore3, O. Groene4,5, L. Gulácsi6, D. Ivankovic1, T. Jansen1,
S. P. Johnsen7, S. de Lusignan8, J. Mainz9, S. Nuti3, N. Klazinga1 and on behalf of the HealthPros Network
Abstract
Background: The COVID-19 pandemic is a complex global public health crisis presenting clinical, organisational
and system-wide challenges. Different research perspectives on health are needed in order to manage and monitor
this crisis. Performance intelligence is an approach that emphasises the need for different research perspectives in
supporting health systems’ decision-makers to determine policies based on well-informed choices. In this paper, we
present the viewpoint of the Innovative Training Network for Healthcare Performance Intelligence Professionals
(HealthPros) on how performance intelligence can be used during and after the COVID-19 pandemic.
Discussion: A lack of standardised information, paired with limited discussion and alignment between countries
contribute to uncertainty in decision-making in all countries. Consequently, a plethora of different non-data-driven
and uncoordinated approaches to address the outbreak are noted worldwide. Comparative health system research
is needed to help countries shape their response models in social care, public health, primary care, hospital care
and long-term care through the different phases of the pandemic. There is a need in each phase to compare
context-specific bundles of measures where the impact on health outcomes can be modelled using targeted data
and advanced statistical methods. Performance intelligence can be pursued to compare data, construct indicators
and identify optimal strategies. Embracing a system perspective will allow countries to take coordinated strategic
decisions while mitigating the risk of system collapse.A framework for the development and implementation of
performance intelligence has been outlined by the HealthPros Network and is of pertinence. Health systems need
better and more timely data to govern through a pandemic-induced transition period where tensions between
care needs, demand and capacity are exceptionally high worldwide. Health systems are challenged to ensure
essential levels of healthcare towards all patients, including those who need routine assistance.
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Conclusion: Performance intelligence plays an essential role as part of a broader public health strategy in guiding
the decisions of health system actors on the implementation of contextualised measures to tackle COVID-19 or any
future epidemic as well as their effect on the health system at large. This should be based on commonly agreed-
upon standardised data and fit-for-purpose indicators, making optimal use of existing health information
infrastructures. The HealthPros Network can make a meaningful contribution.
Keywords: COVID-19, health systems, performance measurement, health services, health information, policy,
evidence
Background
In this paper, we make the case that performance
intelligence plays an essential role in guiding the deci-
sions of health system actors on the implementation of
contextualised Coronavirus disease 2019 (COVID-19)
measures and their effect on patients with non-COVID-
19 health needs. This should be based on commonly
agreed-upon standardised data and fit-for-purpose indi-
cators, making optimal use of existing health informa-
tion infrastructures.
Performance intelligence can be defined as the struc-
tured approach to acting on health policies, using know-
ledge and information generated by the application of
scientific methods to comparable healthcare data to sys-
tematically measure indicators of health systems per-
formance. The COVID-19 pandemic is a complex global
public health crisis, presenting not just clinical but also
organisational and system-wide challenges in the short,
intermediate and longer term. In order to manage and
monitor this crisis, different research perspectives are
needed, including health services research, public health,
epidemiology, sociology, behavioural and political sci-
ences, management, and economics. Performance
intelligence is an approach that emphasises the need for
different research perspectives in supporting health sys-
tems’ decision-makers to determine policies based on
well-informed choices aiming for a whole system scope
and varying time perspectives. Managing the outbreak of
COVID-19 thus becomes an integral part of governing
healthcare systems and not as a separate track with its
own rationale.
The COVID-19 pandemic poses challenges for health
systems that go well beyond the current emergency re-
lated to the treatment of new cases. A risk from the ef-
forts put into managing the crisis is the crowding out of
non-COVID-19 patients, who comprise the vast majority
of those in need of care.
To maximise capacity for the care of COVID-19 pa-
tients, health systems are deliberately delaying many
elective procedures [1–3]. In parallel, it is observed that
patients are refraining from accessing care themselves
due to their fear of coronavirus contamination in hos-
pital or because they do not wish to burden healthcare
workers with their ‘minor’ problems. The effects on pa-
tient groups in need of semi acute care are already be-
coming clear through reported reductions in essential
service utilisation in various countries [4, 5]. In addition,
there are substantial changes in how non-COVID-19
care is delivered through modified protocols [6]. These
changes in the provision of regular care require close
monitoring to inform decision-makers about the appro-
priateness of COVID-19 measures and strategies that
can continue to guarantee (the quality of) essential care
in this and the next phases of the pandemic.
The capacity of health facilities has rightfully been at
the centre of the political debate on the availability of
hospital beds and intensive care units (ICU) during the
outbreak of COVID-19. In most instances, this has
entailed strengthening services with equipment, technol-
ogy and staffing. On the other hand, the role of primary
care has been remarked upon but differently addressed,
with related consequences noted over the course of the
outbreak. For instance, in the decentralised health sys-
tem of Italy, the high fatality rate found in the Lombardy
region (as opposed to the lower rates in the bordering
regions of Veneto and Tuscany) is likely partly explained
by differences in the emphasis on acute hospital and pri-
mary care and testing capacity [7, 8]. In Veneto, a
community-based approach facilitated the testing and
isolation of patients [9]. Moreover, in Lombardy, general
practitioners, although frequently faced with high-risk
situations in caring for their patients at home, were con-
fronted with a lack of personal protective equipment
[10, 11] — 14.3% of all COVID-19 cases in Lombardy
were among healthcare workers, compared with 4.4% in
Veneto, as of 30 March 2020 [9].
Performance measurement, monitoring and reporting
can support the balancing of system approaches to re-
spond to COVID-19 — or any other epidemic — with
targeted strategies such as accurate predictions of hos-
pital admissions and of primary, home and long-term
care needs after discharge. To guide rational and needs-
based decision-making, we have embraced the notion of
‘performance intelligence’ as a compelling solution. In
this paper, we present the viewpoint of the EU-funded
Marie Sklodowska-Curie Innovative Training Network
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for Healthcare Performance Intelligence Professionals
(HealthPros) on how performance intelligence can be
used during and after COVID-19 [12, 13]. Our purpose
is to present the framework of HealthPros, show how its
use can contribute to the resolve of inconsistencies
noted in outbreak responses, and show how it can help
govern national healthcare services and systems, in syn-
ergy with a global research community fully dedicated to
the development of such intelligence. As policies and
practices need to be compared, while leaving room for
different modes of implementation, common knowledge
must build up. Performance intelligence is critical to en-
suring that each territory, be it a council, district, region
or federal state, may choose its own policy based on the
best available evidence for a health system response.
What is performance intelligence and how does it work?
Healthcare performance measurement and its use as
performance intelligence plays an important role in
guiding the decisions of health system actors [14, 15].
Regional, national and international experiences in this
field can be directly translated into solutions that will
help manage the COVID-19 pandemic and its longer-
term impact on health systems and societies, including
during the various transition phases that will gradually
allow a return to a new ‘normal’ life.
Comparative health system research, and its transparent
and timely reporting, is needed to help countries to shape
their response models in social care, public health, pri-
mary care, hospital care and long-term care through the
different phases of the pandemic from pre-disaster to the
reconstruction phases. At each phase in each specific con-
text, there is a need to compare different bundles of mea-
sures, whose impact on health outcomes may be modelled
using targeted data and the application of advanced statis-
tical techniques. Such research starts with agreeing on the
terms for each phase of the COVID-19 pandemic, differ-
entiating countries and geographic areas within countries
to specific stages, and contextualising the characterisation
by the structure of health systems. Responses will need to
address the care continuum of prevention, diagnosis,
treatment and follow-up of COVID-19 patients. Each
stage will require specific epidemiological approaches that
must be capable of considering the regulatory, organisa-
tional, political and cultural context.
As defined, performance intelligence can be used to
gather comparable data, develop indicators and identify
optimal strategies for taking action. For instance, the re-
sponse to COVID-19 could use performance intelligence
to select one or more of the following: (1) considering
substitution effects from hospital to primary care or
long-term care for specific categories of patients (requir-
ing collaboration between health sectors); (2) swapping
tasks between specialities and professions according to
capacity needs; (3) undertaking disruptive innovation
through novel technologies; (4) substantially improving
and optimising the information infrastructure through
data linkage of different databases; (5) analysing different
possible behavioural models of the population and of
health professionals, and the impact of nudging strat-
egies; (6) avoiding disruption in the delivery of the con-
tinuum of care.
The rationale on which pandemic response decisions
are based will need to be explained. Embracing a system
perspective allows countries to take coordinated stra-
tegic decisions and ensure essential levels of healthcare
for all patients (including those who need routine assist-
ance), while mitigating the risk of system collapse.
To facilitate a system perspective, performance
intelligence offers a policy matrix that can be structured
consistent with the Organisation for Economic Cooperation
and Development (OECD) framework of health systems
performance assessment [14]. According to this model
(Fig. 1), three vertical dimensions need to be investigated,
namely effectiveness, safety and responsiveness (population
needs, access, equity). On the horizontal axis, there are
three primary intervention areas at the micro, meso and
macro level. We have populated the matrix with some rele-
vant examples that emerged in the debate following the
COVID-19 outbreak.
At the micro-level, standardised procedures for
COVID-19 patients lack timely examination and are still
largely not monitored in a comparable manner. For ex-
ample, hospitals established different pathways to receive
suspected cases, which may eventually lead to the uncon-
trolled spread of the disease. Similarly, there has been dis-
cussion on evidence-based approaches to prioritising
groups at high-risk of complications such as patients with
specific case-mixes identified from multivariable risk ad-
justment and on testing for subgroups exposed to the in-
fection or subjects with symptoms. Further, best practices
for personal safety remain unclear.
At the meso-level, the role and rules of engagement of
professionals and healthcare providers have been quite
heterogeneous. Some countries (or regions in decentra-
lised countries) prioritised acute settings, while others
invested more in community care intervention and mon-
itoring [16]. The relative merits of different approaches
should be formally evaluated in the course of the pan-
demic to make sure that timely corrective actions may
be undertaken to achieve the best possible outcomes.
At the macro-level, there has been enormous pressure
on the supply side, even prior to knowing the most ef-
fective solutions and, in some cases, even disagreeing on
the effectiveness and/or accuracy of some products. All
countries are concerned about (potential) shortages of
protective personal equipment, tests and ventilators [17].
The demand caused an avoidable competition between
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countries, later followed by more targeted strategies to
convert internal production, with an adequate level of
intelligence. Finally, the struggle to increase capacity
pushed countries like Ireland and Spain to ‘nationalise’
private facilities in addition to public hospitals [18, 19].
However, it is still unclear whether such solutions offer
the highest standards of safety required to assist patients
infected with COVID-19.
Performance intelligence is essential to support those
decisions through accurate modelling and structured
comparison of the systems in place (e.g. ICU), the out-
comes achieved (e.g. survival) and the finely tuned popu-
lation (including non-COVID-19) health needs (e.g.
percentage of high-risk susceptible persons). Sharing
available expertise within and between countries and
capitalising on expertise (e.g. the OECD Health Care In-
dicators Project and the HealthPros network) may pro-
vide a springboard for a global response.
Performance intelligence may help to improve pan-
demic preparedness in many ways, even for aspects not
directly related to the disease itself. A relevant case is
that of preventing unwarranted side effects related to the
disruption of services for urgent care management (e.g.
cancer patients undergoing chemotherapy or people
with diabetes under dialysis).
To respond to these challenges, the research activities
involved require mobilising a substantial capacity of
interdisciplinary experts from the diverse fields of social
sciences, public administration, health economics, health
services research, political science, health policy and
management, biostatistics, clinical epidemiology, medi-
cine, improvement science and health information.
Moreover, investing in this capacity through competen-
cies for performance intelligence is essential.
The role of information infrastructure in enabling
performance intelligence
Many countries and regions have adapted their data
privacy legislation to increase opportunities for data
sharing and are currently relaxing this carefully balanced
legislation [20]. This will require continuous close
monitoring by organisations such as the OECD and
WHO. The response to the disease will require a sub-
stantial increased effort to assess how the existing data
systems in place, such as clinical registries, administra-
tive data and electronic medical records, next to estab-
lished infectious diseases surveillance systems can be
used for monitoring and surveillance as well as for
informing capacity planning and management. Such cap-
acity may be able to assist countries during this and any
other unfortunate circumstances that may challenge the
resilience of our healthcare systems.
A relevant and still insufficiently addressed issue is
monitoring changes over time regarding disparities in
quality of healthcare for both vulnerable and at-risk pop-
ulations. These will require detailed data collection (and
linkages) of multiple characteristics such as demograph-
ics (age, gender, etc.), proxies of income and education
(e.g. socioeconomic status and health literacy), and the
clinical and personal case-mix (e.g. comorbidity burden,
migration status and ethnicity). This will inform, among
others, the required stratification needed to tailor strat-
egies in services delivery, tackling determinants and en-
suring access for all.
For any outbreak, multiple databases will have to be
linked across sectors to include information from people
with and without the disease. That is because risk ad-
justment should compare multivariable patterns for both
exposed and non-exposed groups. For instance, the
evaluation of care for COVID-19 patient needs also de-
tailed data on non-COVID-19 individuals, which may
not be possible to collect accurately without available
population-based data (e.g. using a common ID for a
representative control sample of all citizens) [20]. In
most cases, this would require implementing routine
data collection in regular systems of care (e.g. general
practitioner information systems). This would allow so-
phisticated analysis, for example, to identify selection
bias in access to care. Accurate data may also directly
allow automated checks of anecdotal reports from clini-
cians in countries (e.g. Italy) informing patient allocation
decisions for the ICU given the scarcity of resources and
Fig. 1 Performance Intelligence Outbreak Preparedness Matrix: dimensions and example of relevant policies
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based on personal preferences and characteristics associ-
ated with a higher likelihood of survival (e.g. age and co-
morbidities) [21, 22]. The British Medical Association
has already included this in their latest clinical guidelines
[23]. Potential disparities in prevention, diagnosis, treat-
ment and follow-up care should be also monitored. For
instance, deprived COVID-19 patients might have a
lower likelihood of admission to hospital or ICU, result-
ing in lower survival. The present crisis should not in-
crease disparities but should rather be seen as an
opportunity to capture all relevant data that is necessary
to reduce them. Only if we start from a consolidated
measurement system already in use, is it possible to
measure the impact of the emergency, which is neces-
sary to introduce changes in the actions taken in the
event of a problem [15].
An aspect of responsiveness that deserves particular at-
tention during an outbreak such as COVID-19 is that of
mental health. The conditions imposed by central govern-
ments may lead to elevated levels of anxiety or depression
related to the imposed physical distancing, quarantine,
lockdown measures or job losses, each of which should be
investigated in their own right. This should be closely
monitored to address the situation in a timely manner, for
instance, by including patient-reported experience and
outcome measures (PREMS and PROMS) in regular sur-
veys and integrating this in clinical practice [24]. In most
countries, data on the quality of mental healthcare is cur-
rently scarce and often limited to utilisation and, at times,
to suicide data. Researchers are urged to explore the possi-
bilities to exchange and replicate patient-reported out-
come measures/patient-reported experience measures
survey questions in their ongoing and future research to
contribute to such intelligence. Special attention should
be given to assessing the mental health status of health-
care professionals and to interventions to ensure that the
healthcare workforce remains healthy [25].
The data needed to populate the proposed matrix may
ensure better alignment between needs, demands and
actual use of healthcare services, in times of emergency
and scarcity of resources. This will require case studies
modelled on country experiences and involve consider-
able investment to scale-up the current information in-
frastructure. Some countries provide relevant examples.
For example, the primary care national surveillance sys-
tem of the Royal College of General Practitioners Re-
search and Surveillance Centre in England has a
mandate to monitor the occurrence of cases for COVID-
19 [26]. Also, countries like Finland (Findata) and South
Korea (HIRA) demonstrate how their present informa-
tion infrastructure can be put at the service of the nation
to manage this crisis [27]. These cases may help in iden-
tifying opportunities, forming recommendations and
sharing lessons across countries on how to optimise the
existing information infrastructure for performance
intelligence in a coherent and standardised manner [28].
How to implement a performance intelligence framework
to inform policies against COVID-19
The heterogeneous responses of governments threatened
by COVID-19 did not seem to prioritise the need for
creating a common performance intelligence framework
as a basis for common evidence-based policies [29]. Ex-
perts have struggled to deliver stable forecasts, using
models that rely on aggregate and partly inaccurate data,
contributing to alarming estimates of death that required
later adjustments [29–31]. During the first 3 months of
the pandemic, the usual dissemination means, including
research abstracts and publications, were used to inform
governments, not infrequently with contrasting mes-
sages. A common problem of this approach is that the
data underpinning results such as comparisons between
fatality rates and projected trends of pandemics are
mostly aggregated and not fit for purpose to contribute
to specific models.
A framework for the implementation of performance
intelligence has been outlined by partners of the Health-
Pros Network [12, 13]. The diagram (Fig. 2) presents a
hierarchical structure with healthcare data and indica-
tors at the base of performance measurement. These are
fundamental elements that have been found to be weak
since the inception of COVID-19, notwithstanding the
recent expansion of electronic information systems that
accelerated the speed, increased the volume and ex-
tended the range in types of data available [32].
During the current COVID-19 crisis, we have observed
the paramount importance of available data with the right
information, in the right hands at the right time. Although
different platforms have evolved overnight [33, 34], the
challenge is not a shortage of the technology or our ability
to collect data but rather their meaningfulness.
Fig. 2 The hierarchical structure of a performance
intelligence framework
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Developing our understanding of what makes an indicator
actionable for decision-makers is of critical importance to
ensure that we fully leverage our data in day-to-day opera-
tions and in times of health emergencies. Such leverage
will require the standardisation of definitions, recording,
use of ontologies and common data models to enable
international comparison. First steps have been created on
Bioportal [35, 36]. In times of crisis, trust in data should
not be overlooked. While in public announcements WHO
and the European Centre for Disease Prevention and Con-
trol did not compare the number of confirmed cases and
case fatality of COVID-19, country comparisons are made
in their dashboards [37, 38]. These hide differentiation in
testing policies and in definitions of mortality and case
calculations (case ascertainment), include no mentioning
of mean age or comorbidities, and are severely affected by
a disproportionate lack of coding COVID-19-related
deaths in nursing homes; these features leave room for
misinterpretation [39]. Such global rankings are therefore
of limited utility.
At a higher level in the pyramid of performance
intelligence we find the need to translate indicators into
the knowledge and information used for governance. At
this level, decision-makers have a specific purpose to use
healthcare performance data in relation to the COVID-
19 pandemic across the macro, meso and micro-levels of
the health system outlined above. Therefore, at the high-
est level of the pyramid, we position the need to utilise
data and knowledge in order to act in response to a spe-
cific problem. Each purpose demands different informa-
tion for decision-makers. Particularly in times of
emergency, different methodological considerations will
determine the actionability of performance intelligence.
The time-sensitive nature of indicators and the need for
standardised data are critical factors. Standardisation en-
ables the comparability and analysis of indicators and fa-
cilitates trust in data.
At the two opposing ends of the pyramid we position
management and dissemination. Implementation of the
framework within and across countries may be particu-
larly complex, requiring coordination and facing many
barriers (such as data protection rules and data ex-
change) that can be hampered by administrative hurdles
(e.g. decentralisation) and international boundaries. Dis-
semination is key to making information accessible to
the broader population. The general public uses data on
COVID-19 to form an opinion on the success of their
governmental response and determines trust in their re-
sponsiveness. While the underlying methodology cannot
be simplistic, the availability of easily interpreted data is
particularly important. The public is overwhelmed by
the availability of popular indicators such as daily case
fatality and incidence rates. Evidently, most measures
hide time lag effects (e.g. test results relative to samples
taken days before and/or hospitals reporting data asyn-
chronously) or may be far from accurate (e.g. under-
estimated mortality rates due to denominators biased by
limited testing capacity). As a result, the magnitude of
indicators published in the public domain often does not
match public statements from policy-makers about the
effect of their policies. For example, a policy-maker in
charge of an ICU may plan capacity 2 weeks ahead based
on today’s infection incidence rate. If that rate decreases,
the plan will be optimistic and not aligned with expecta-
tions of the public.
Good quality data is pivotal for intelligence during the
COVID-19 pandemic and beyond. In HealthPros, we in-
vest in training a future workforce with performance
intelligence competencies, which directly links the cre-
ation of a new generation of performance intelligence
professionals to all layers of pyramid of intelligence. This
is much needed to ensure preparedness for the transi-
tion strategy of COVID-19 and any possible other unfor-
tunate circumstances that may challenge the resilience
of our healthcare systems for which countries can find
this framework ready for use.
Through the Innovative Training Network, we have
access to many different databases and hold interdiscip-
linary expertise. Here, we see the opportunity but also
feel the obligation to apply the project to address a num-
ber of questions that are key to assuring the proper
functioning of health services and use of health data dur-
ing epidemics.
Conclusion
Performance intelligence plays an essential role as part
of a broader public health strategy in guiding the deci-
sions of health system actors on the implementation of
contextualised measures to tackle COVID-19 or any fu-
ture epidemic and their effect on the health system at
large. This should be based on commonly agreed-upon
standardised data and related systems of indicators,
making optimal use of existing health information infra-
structures. We urge policy-makers to support the devel-
opment and use of performance intelligence based on
this vision and invite other health services researchers to
join and further strengthen this approach for the endur-
ing transformation of pandemic-resilient health systems.
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